433 related articles for article (PubMed ID: 20701405)
1. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I; Arcavi L; Schechmaster R; Akayzen Y; Popliski H; Shimonov J; Beig S; Berkovitch M
Drug Saf; 2010 Sep; 33(9):713-26. PubMed ID: 20701405
[TBL] [Abstract][Full Text] [Related]
2. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Belfield KD; Tichy EM
Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
[TBL] [Abstract][Full Text] [Related]
3. G6PD deficiency: a classic example of pharmacogenetics with on-going clinical implications.
Luzzatto L; Seneca E
Br J Haematol; 2014 Feb; 164(4):469-80. PubMed ID: 24372186
[TBL] [Abstract][Full Text] [Related]
4. Diabetic ketoacidosis does not precipitate haemolysis in patients with the Mediterranean variant of glucose-6-phosphate dehydrogenase deficiency.
Shalev O; Wollner A; Menczel J
Br Med J (Clin Res Ed); 1984 Jan; 288(6412):179-80. PubMed ID: 6419846
[TBL] [Abstract][Full Text] [Related]
5. Single Low Dose Primaquine (0.25 mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects.
Bancone G; Chowwiwat N; Somsakchaicharoen R; Poodpanya L; Moo PK; Gornsawun G; Kajeechiwa L; Thwin MM; Rakthinthong S; Nosten S; Thinraow S; Nyo SN; Ling CL; Wiladphaingern J; Kiricharoen NL; Moore KA; White NJ; Nosten F
PLoS One; 2016; 11(3):e0151898. PubMed ID: 27010542
[TBL] [Abstract][Full Text] [Related]
6. Glucose-6-phosphate dehydrogenase deficiency.
Cappellini MD; Fiorelli G
Lancet; 2008 Jan; 371(9606):64-74. PubMed ID: 18177777
[TBL] [Abstract][Full Text] [Related]
7. Adverse effects of herbal or dietary supplements in G6PD deficiency: a systematic review.
Lee SW; Lai NM; Chaiyakunapruk N; Chong DW
Br J Clin Pharmacol; 2017 Jan; 83(1):172-179. PubMed ID: 27081765
[TBL] [Abstract][Full Text] [Related]
8. Screening for glucose-6-phosphate dehydrogenase deficiency prior to dapsone therapy.
Todd P; Samaratunga IR; Pembroke A
Clin Exp Dermatol; 1994 May; 19(3):217-8. PubMed ID: 8033379
[TBL] [Abstract][Full Text] [Related]
9. G6PD gene mutations in India producing drug-induced haemolytic anaemia.
Sukumar S; Colah R; Mohanty D
Br J Haematol; 2002 Mar; 116(3):671-2. PubMed ID: 11849231
[TBL] [Abstract][Full Text] [Related]
10. Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.
Gammal RS; Pirmohamed M; Somogyi AA; Morris SA; Formea CM; Elchynski AL; Oshikoya KA; McLeod HL; Haidar CE; Whirl-Carrillo M; Klein TE; Caudle KE; Relling MV
Clin Pharmacol Ther; 2023 May; 113(5):973-985. PubMed ID: 36049896
[TBL] [Abstract][Full Text] [Related]
11. Perioperative management of the glucose-6-phosphate dehydrogenase deficient patient: a review of literature.
Elyassi AR; Rowshan HH
Anesth Prog; 2009; 56(3):86-91. PubMed ID: 19769422
[TBL] [Abstract][Full Text] [Related]
12. An audit of the precipitating factors for haemolytic crisis among glucose-6-phosphate dehydrogenase-deficient paediatric patients.
Al-Azzam SI; Al-Ajlony MJ; Al-Khateeb T; Alzoubi KH; Mhaidat N; Ayoub A
J Med Screen; 2009; 16(4):167-9. PubMed ID: 20054089
[TBL] [Abstract][Full Text] [Related]
13. Central retinal vein occlusion in an Army ranger with glucose-6-phosphate dehydrogenase deficiency.
Kotwal RS; Butler FK; Murray CK; Hill GJ; Rayfield JC; Miles EA
Mil Med; 2009 May; 174(5):544-7. PubMed ID: 20731290
[TBL] [Abstract][Full Text] [Related]
14. Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review.
Pankey AN; Chandar A; Isaacson G
Laryngoscope; 2022 Jun; 132(6):1300-1305. PubMed ID: 34546579
[TBL] [Abstract][Full Text] [Related]
15. [Drug-induced hemolysis in patients with glucose-6-phosphate dehydrogenase deficiency].
Grieger M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1983; 110(5):692-703. PubMed ID: 6198253
[TBL] [Abstract][Full Text] [Related]
16. Severe acute haemolytic anaemia associated with severe methaemoglobinaemia in a G6PD-deficient man.
Rehman A; Shehadeh M; Khirfan D; Jones A
BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29592989
[TBL] [Abstract][Full Text] [Related]
17. Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study.
Ganapathi M; Campbell P; Ofori K; Aggarwal V; Francis RO; Kratz A
Br J Clin Pharmacol; 2022 Sep; 88(9):4163-4170. PubMed ID: 35419830
[TBL] [Abstract][Full Text] [Related]
18. Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase-deficient children receiving dapsone.
Pamba A; Richardson ND; Carter N; Duparc S; Premji Z; Tiono AB; Luzzatto L
Blood; 2012 Nov; 120(20):4123-33. PubMed ID: 22993389
[TBL] [Abstract][Full Text] [Related]
19. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
Rajapakse S; Rodrigo C; Fernando SD
Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
[TBL] [Abstract][Full Text] [Related]
20. Association of Hydroxychloroquine use and Hemolytic Anemia in Patients With Low Levels of Glucose-6-Phosphate Dehydrogenase.
Ramirez de Oleo IE; Mejia Saldarriaga M; Johnson BK
J Clin Rheumatol; 2022 Jan; 28(1):e23-e25. PubMed ID: 32956151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
